Volume 1, Issue 3, Pages (May 2007)

Slides:



Advertisements
Similar presentations
Smita Srivastava, Patricia S. Grace, Joel D. Ernst  Cell Host & Microbe 
Advertisements

Two Phases of Astral Microtubule Activity during Cytokinesis in C
Fanny Jaulin, Xiaoxiao Xue, Enrique Rodriguez-Boulan, Geri Kreitzer 
RhoD Inhibits RhoC-ROCK-Dependent Cell Contraction via PAK6
Volume 12, Issue 1, Pages (July 2012)
Volume 14, Issue 5, Pages (November 2013)
Volume 12, Issue 3, Pages (September 2012)
F11L-Mediated Inhibition of RhoA-mDia Signaling Stimulates Microtubule Dynamics during Vaccinia Virus Infection  Yoshiki Arakawa, João V. Cordeiro, Michael.
Volume 3, Issue 5, Pages (May 2008)
Volume 15, Issue 1, Pages (January 2014)
Volume 22, Issue 5, Pages (May 2012)
Volume 28, Issue 6, Pages e3 (March 2018)
Volume 136, Issue 6, Pages (March 2009)
Rui Pedro Galão, Suzanne Pickering, Rachel Curnock, Stuart J.D. Neil 
Entrapment of Intracytosolic Bacteria by Septin Cage-like Structures
Single-Molecule Microscopy Reveals Plasma Membrane Microdomains Created by Protein-Protein Networks that Exclude or Trap Signaling Molecules in T Cells 
Volume 3, Issue 5, Pages (May 2008)
Volume 27, Issue 1, Pages (July 2007)
Stuart W. Hicks, Guillaume Charron, Howard C. Hang, Jorge E. Galán 
Volume 14, Issue 1, Pages (January 2004)
Volume 36, Issue 3, Pages (February 2016)
Coupling of Homologous Recombination and the Checkpoint by ATR
Distinct Autophagosomal-Lysosomal Fusion Mechanism Revealed by Thapsigargin- Induced Autophagy Arrest  Ian G. Ganley, Pui-Mun Wong, Noor Gammoh, Xuejun.
Volume 30, Issue 3, Pages (August 2014)
Smita Srivastava, Patricia S. Grace, Joel D. Ernst  Cell Host & Microbe 
Volume 22, Issue 4, Pages e5 (October 2017)
Phospholipid Scramblase 1 Mediates Type I Interferon-Induced Protection against Staphylococcal α-Toxin  Miroslaw Lizak, Timur O. Yarovinsky  Cell Host.
Jungmook Lyu, Vicky Yamamoto, Wange Lu  Developmental Cell 
Volume 9, Issue 6, Pages (June 2011)
Samuel F. Bakhoum, Giulio Genovese, Duane A. Compton  Current Biology 
The Formin FMNL3 Controls Early Apical Specification in Endothelial Cells by Regulating the Polarized Trafficking of Podocalyxin  Mark Richards, Clare.
Maïlys A.S. Vergnolle, Stephen S. Taylor  Current Biology 
Volume 7, Issue 5, Pages (May 2010)
Volume 15, Issue 2, Pages (February 2014)
Marko Kaksonen, Christopher P. Toret, David G. Drubin  Cell 
Nucleocapsid Phosphorylation and RNA Helicase DDX1 Recruitment Enables Coronavirus Transition from Discontinuous to Continuous Transcription  Chia-Hsin.
A Superhighway to Virus Infection
Cytoplasmic ATR Activation Promotes Vaccinia Virus Genome Replication
The Actin-Bundling Protein Palladin Is an Akt1-Specific Substrate that Regulates Breast Cancer Cell Migration  Y. Rebecca Chin, Alex Toker  Molecular.
Volume 9, Issue 4, Pages (April 2011)
Volume 29, Issue 5, Pages (June 2014)
Yiuka Leung, Shabeen Ally, Marcia B. Goldberg  Cell Host & Microbe 
Salmonella SPI1 Effector SipA Persists after Entry and Cooperates with a SPI2 Effector to Regulate Phagosome Maturation and Intracellular Replication 
F11L-Mediated Inhibition of RhoA-mDia Signaling Stimulates Microtubule Dynamics during Vaccinia Virus Infection  Yoshiki Arakawa, João V. Cordeiro, Michael.
Mark P. Dodding, Michael Way  Cell Host & Microbe 
May K. Wang, Sun-Young Lim, Soo Mi Lee, James M. Cunningham 
Volume 8, Issue 4, Pages (October 2010)
Sara K. Donnelly, Ina Weisswange, Markus Zettl, Michael Way 
Samuel F. Bakhoum, Giulio Genovese, Duane A. Compton  Current Biology 
The UCS Domain Protein She4p Binds to Myosin Motor Domains and Is Essential for Class I and Class V Myosin Function  Stefanie Wesche, Marc Arnold, Ralf-Peter.
Yuri Oleynikov, Robert H. Singer  Current Biology 
Protein Kinase D Inhibitors Uncouple Phosphorylation from Activity by Promoting Agonist-Dependent Activation Loop Phosphorylation  Maya T. Kunkel, Alexandra C.
Kohei Arasaki, Derek K. Toomre, Craig R. Roy  Cell Host & Microbe 
Vaccinia Virus F11 Promotes Viral Spread by Acting as a PDZ-Containing Scaffolding Protein to Bind Myosin-9A and Inhibit RhoA Signaling  Yutaka Handa,
Yun Wah Lam, Angus I. Lamond, Matthias Mann, Jens S. Andersen 
Volume 11, Issue 4, Pages (April 2012)
Volume 19, Issue 8, Pages (April 2009)
Polo-like Kinase 1 Triggers the Initiation of Cytokinesis in Human Cells by Promoting Recruitment of the RhoGEF Ect2 to the Central Spindle  Mark Petronczki,
Three-Step Model for Polarized Sorting of KIF17 into Dendrites
Volume 128, Issue 3, Pages (February 2007)
Fanny S. Chang, Christopher J. Stefan, Kendall J. Blumer 
Volume 22, Issue 14, Pages (July 2012)
Takashi Hayashi, Gavin Rumbaugh, Richard L. Huganir  Neuron 
Volume 2, Issue 6, Pages (December 2007)
Life-Saving Degeneracy in the Human Immune System
Taro Ohkawa, Matthew D. Welch  Current Biology 
Volume 134, Issue 1, Pages (July 2008)
Marko Kaksonen, Yidi Sun, David G. Drubin  Cell 
Volume 65, Issue 5, Pages e4 (March 2017)
Translocation of a Vibrio cholerae Type VI Secretion Effector Requires Bacterial Endocytosis by Host Cells  Amy T. Ma, Steven McAuley, Stefan Pukatzki,
Presentation transcript:

Volume 1, Issue 3, Pages 227-240 (May 2007) The Release of Vaccinia Virus from Infected Cells Requires RhoA-mDia Modulation of Cortical Actin  Yoshiki Arakawa, João V. Cordeiro, Sibylle Schleich, Timothy P. Newsome, Michael Way  Cell Host & Microbe  Volume 1, Issue 3, Pages 227-240 (May 2007) DOI: 10.1016/j.chom.2007.04.006 Copyright © 2007 Elsevier Inc. Terms and Conditions

Figure 1 Stabilizing Microtubules Inhibits Virus Release (A) Immunofluorescence images of the actin cytoskeleton, extracellular cell-associated enveloped virus (CEV = B5R), or intracellular and extracellular enveloped virus (IEV + CEV = F13L) particles in cells infected with WR for 10 hr after treatment with nocodazole or paclitaxel for the previous 2 hr. (B) Quantitative analyses of the actin tail positive cell rate and the number of actin tails in cells treated with nocodazole or paclitaxel. (C) Representative immunofluorescence images of cells infected with the A36R-YdF strain of vaccinia, which is deficient in actin tail formation, reveal that treatment with nocodazole or paclitaxel results in loss of extracellular virus particles. (D) Quantitative analyses of the number of infectious particles released from WR- and A36R-YdF-infected cells treated with the indicated drug. Error bars represent SEM; ∗∗∗p < 0.0001. All scale bars, 20 μm. Cell Host & Microbe 2007 1, 227-240DOI: (10.1016/j.chom.2007.04.006) Copyright © 2007 Elsevier Inc. Terms and Conditions

Figure 2 Actin Cytoskeleton Organization Modulates Virus Release (A) Microtubule-dependent movement of intracellular enveloped virus (IEV) visualized with A36R-YdF-YFP with or without paclitaxel treatment. Whole-cell panel shows IEV virus particle distribution and tracks over 56 s, while the smaller panels represent movie stills from the highlighted area (see Movie S1). (B) Quantitative analyses of the number of infectious particles released from WR-infected cells treated with the indicated drug. (C) Quantitative analyses of the number of infectious particles released from WR-infected cells treated with the indicated drug (left). Quantitative analyses of the actin tail positive cell rate and the number of actin tails in cells treated with the indicated drug (middle, right). (D) Time-lapse images of the periphery of a cell infected with the A36R-YdF-YFP virus reveal that addition of 0.1 μM Latrunculin B but not DMSO stimulates rapid movement of IEV virus particles to the plasma membrane (see Movie S2). (E) Analyses of the number of virus particles 0–4 and 4–10 μm from the cell margin after a 5 min treatment with 0.1 μM Latrunculin B or DMSO in A36R-YdF-infected cells. Error bars represent SEM; ∗∗∗p < 0.0001. All scale bars, 20 μm. Cell Host & Microbe 2007 1, 227-240DOI: (10.1016/j.chom.2007.04.006) Copyright © 2007 Elsevier Inc. Terms and Conditions

Figure 3 Actin-Dependent Movement of Virus Particles in the Cell Periphery (A) Movement of intracellular enveloped virus (IEV) visualized with A36R-YdF-YFP in the cell cortex before and after first paclitaxel addition and second 0.1 μM Latrunculin B. Smaller panels represent movie stills from the highlighted area in main cell. Color-coded tracks of the movements of virus particles over 26 s for each drug regime are indicated above each movie still (see Movie S3). (B) Quantitative analyses of the number of virus particles 0–4 and 4–10 μm from the cell margin after treatment with DMSO for 30 min, paclitaxel for 30 min, or 0.1 μM Latrunculin B (5 min) following 30 min incubation in paclitaxel in A36R-YdF-infected cells. (C) Color-coded tracks of IEV particle movements in the cell cortex over 26 s before and after the indicated drug (see Movies S4 and S5). (D) Confocal laser scanning images of actin cytoskeleton at the bottom of WR-infected cells expressing YFP-actin confirm that treatment with paclitaxel stimulates actin polymerization in the cell periphery. (E) Quantitative analysis of the relative intensity of cortical actin in WR-infected cells expressing YFP-actin treated with DMSO or paclitaxel. (F) Immunoblot and quantitative analysis of Rho activity in WR-infected cells treated with paclitaxel. Error bars represent SEM. All scale bars, 20 μm. Cell Host & Microbe 2007 1, 227-240DOI: (10.1016/j.chom.2007.04.006) Copyright © 2007 Elsevier Inc. Terms and Conditions

Figure 4 RhoA Signaling Inhibits Virus Release by Stimulating Actin Polymerization (A) Immunofluorescence images of extracellular cell-associated enveloped virus (CEV = B5R) or intracellular and extracellular enveloped virus (IEV + CEV = F13L) particles in WR-infected cells expressing GFP-tagged RhoA V14 and RhoA N19 and treated with 0.1 μM Latrunculin B. (B) Quantitative analyses of the actin tail positive cell rate and the number of actin tails in WR-infected cells expressing the indicated GFP-tagged protein. (C) Quantitative analyses of the number of infectious virus particles released from WR-infected cells expressing the indicated protein and treated with the indicated drugs. Error bars represent SEM; ∗∗∗p < 0.0001. Cell Host & Microbe 2007 1, 227-240DOI: (10.1016/j.chom.2007.04.006) Copyright © 2007 Elsevier Inc. Terms and Conditions

Figure 5 An Interaction of F11L with RhoA Is Required to Promote Virus Release (A) Representative immunofluorescence images of the actin cytoskeleton, CEV (B5R), or IEV and CEV (F13L) particles in WR-infected cells expressing GFP-F11L-VK, which cannot bind RhoA, with or without TAT-C3 treatment. (B) Quantitative analyses of the actin tail positive cell rate and the number of actin tails in WR-infected cells expressing GFP-F11L-VK with or without TAT-C3 treatment. (C) Immunofluorescence images of CEV (B5R) and IEV + CEV (F13L) in WR-infected cells expressing GFP-F11L-VK in the presence or absence of TAT-C3. (D) Quantitative analyses of the number of infectious particles released from WR-infected cells expressing GFP-F11L-VK in the presence or absence of TAT-C3. (E) Immunoblot analyses of pull-down assays reveal that GST-tagged F11L or F11L-VK is able to interact with endogenous F11L during WR infection. Error bars represent SEM; ∗∗p < 0.001, ∗∗∗p < 0.0001. Cell Host & Microbe 2007 1, 227-240DOI: (10.1016/j.chom.2007.04.006) Copyright © 2007 Elsevier Inc. Terms and Conditions

Figure 6 ROCK Is Not Required for Microtubule-Dependent Virus Release (A) Immunofluorescence images of the actin cytoskeleton, CEV (B5R), or IEV and CEV (F13L) particles in WR-infected cells treated with the indicated drugs or TAT-C3. (B) Quantitative analyses of the actin tail positive cell rate and the number of actin tails in WR-infected cells in the various treatments. (C) Quantitative analysis of the number of infectious particles released from WR-infected cells treated with the indicated drugs. Error bars represent SEM; ∗∗∗p < 0.0001. Cell Host & Microbe 2007 1, 227-240DOI: (10.1016/j.chom.2007.04.006) Copyright © 2007 Elsevier Inc. Terms and Conditions

Figure 7 mDia-Mediated Actin Polymerization Inhibits Virus Particle Release (A) Immunofluorescence images of the actin cytoskeleton, CEV (B5R), or IEV and CEV (F13L) particles in WR-infected cells expressing GFP-tagged active forms of mDia1 (mDia1 ΔN3) and ROCK1 (ROCK1 Δ3), in the presence or absence of 0.1 μM Latrunculin B. (B) Quantitative analyses of the actin tail positive cell rate and the number of actin tails in WR-infected cells expressing mDia1 ΔN3 and ROCK1 Δ3. (C) Quantitative analyses of the number of infectious particles released from WR-infected cells expressing the indicated GFP-tagged protein in the presence or absence of 0.1 μM Latrunculin B. (D) Movement of IEV particles in cells infected with A36R-YdF-YFP and expressing mDia1 ΔN3 and RhoA V14. Smaller panels represent movie stills from the highlighted area in main cell. Color-coded tracks of the movements of virus particles over 26 s for each drug regime are indicated above each movie still (Movie S6). (E) Schematic representation of F11L-mediated inhibition of RhoA-mDia signaling, which results in increased microtubules dynamics and changes in cortical actin that promote virus particle release. Error bars represent SEM; ∗∗∗p < 0.0001. Cell Host & Microbe 2007 1, 227-240DOI: (10.1016/j.chom.2007.04.006) Copyright © 2007 Elsevier Inc. Terms and Conditions